WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 314223
Description: Gadobutrol is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer Schering Pharma as Gadovist, and by Bayer HealthCare Pharmaceuticals as Gadavist. (Source: http://en.wikipedia.org/wiki/Gadobutrol).
MedKoo Cat#: 314223
Chemical Formula: C18H31GdN4O9
Exact Mass: 605.1332
Molecular Weight: 604.71
Elemental Analysis: C, 35.75; H, 5.17; Gd, 26.00; N, 9.27; O, 23.81
Gadobutrol is not in stock, but may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to email@example.com to inquire quote.
Synonym: Gd-DO3A-butrol; ZK 135079; Gadobutrol, Gadograf; Gadovist, Gadavist.
IUPAC/Chemical Name: gadolinium(III) 2,2',2''-(10-((2R,3S)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl)triacetate
InChi Key: ZPDFIIGFYAHNSK-CTHHTMFSSA-K
InChi Code: InChI=1S/C18H34N4O9.Gd/c23-12-14(15(25)13-24)22-7-5-20(10-17(28)29)3-1-19(9-16(26)27)2-4-21(6-8-22)11-18(30)31;/h14-15,23-25H,1-13H2,(H,26,27)(H,28,29)(H,30,31);/q;+3/p-3/t14-,15-;/m1./s1
SMILES Code: OC[C@@H](O)[C@H](N1CCN(CC([O-])=O)CCN(CC([O-])=O)CCN(CC([O-])=O)CC1)CO.[Gd+3]
The following data is based on the product molecular weight 604.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||1.15 mL||5.76 mL||11.51 mL|
|5 mM||0.23 mL||1.15 mL||2.3 mL|
|10 mM||0.12 mL||0.58 mL||1.15 mL|
|50 mM||0.02 mL||0.12 mL||0.23 mL|